Search Results 1111-1120 of 18421 for Immunode
In order for patients with human immunodeficiency virus (HIV) or known acquired immunodeficiency syndrome (AIDS) to be eligible, they must be on a stable ...
* Has human immunodeficiency virus infection; patients who are taking an effective antiviral therapy with undetectable viral load prior to C1D1 are eligible.
Patients with a history of human immunodeficiency virus (HIV) infection must be on an effective anti-retroviral regimen utilizing agents that do not ...
Immunocompromised patients and patients known to be human immunodeficiency virus (HIV) positive and currently receiving antiretroviral therapy; Note ...
* Known human immunodeficiency virus (HIV) infection. * Active hepatitis C infection. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...
Patients must not be hepatitis B, hepatitis C or human immunodeficiency virus (HIV) positive as these conditions could interfere with endpoint assessment ...
Known human immunodeficiency virus (HIV) unless CD4+ T cell count > 350 cells/µL with an undetectable viral load. Active infection that requires systemic ...
Known immunodeficiency; Chronic, active viral infections, including HIV-1/2, HTLV-1/2, hepatitis B/C; Known autoimmune disease (e.g., rheumatoid arthritis or ...
Current Antiretroviral Treatment Among People With Human Immunodeficiency Virus in the United States: Findings from the Centers for AIDS Research Network of ...
HIV is an infection with the human immunodeficiency virus. HIV interferes with the body's ability to fight off viruses, bacteria and fungi that cause ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.